PROGESTERONE RECEPTOR POSITIVE
Clinical trials for PROGESTERONE RECEPTOR POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PROGESTERONE RECEPTOR POSITIVE trials appear
Sign up with your email to follow new studies for PROGESTERONE RECEPTOR POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: Pre-Surgery combo shrinks breast tumors
Disease control OngoingThis study tested whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery helps shrink breast cancer tumors in 92 women with early-stage or locally advanced breast cancer. The goal was to see if the treatment redu…
Matched conditions: PROGESTERONE RECEPTOR POSITIVE
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could Pre-Surgery radiation shrink breast tumors and spare healthy tissue?
Disease control OngoingThis study tests whether giving radiation therapy before surgery can shrink tumors in people with hormone receptor-positive, HER2-negative breast cancer. The goal is to make the tumor smaller so less healthy tissue needs to be removed during surgery. The trial involves 25 adults …
Matched conditions: PROGESTERONE RECEPTOR POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New scan may predict hormone therapy response in advanced breast cancer
Diagnosis OngoingThis study tests whether a special PET scan called FES can predict how well hormone therapy will work in people with newly diagnosed breast cancer that has spread. About 99 participants will get the scan, which uses a radioactive form of estrogen to "light up" cancer cells. The g…
Matched conditions: PROGESTERONE RECEPTOR POSITIVE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC